Cameron B Morrison
Overview
Explore the profile of Cameron B Morrison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sines B, Morrison C, Donaldson J, Ahmad A, Krishnamurthy A, Peden D, et al.
Ann Am Thorac Soc
. 2024 Nov;
22(3):339-349.
PMID: 39499775
Epidemiologic studies on patients with asthma and data suggest a protective role of type 2 (T2) inflammation in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Using a large, multisite...
2.
Donoghue L, Markovetz M, Morrison C, Chen G, McFadden K, Sadritabrizi T, et al.
Am J Physiol Lung Cell Mol Physiol
. 2023 Oct;
325(6):L765-L775.
PMID: 37847709
Airway mucociliary clearance (MCC) is required for host defense and is often diminished in chronic lung diseases. Effective clearance depends upon coordinated actions of the airway epithelium and a mobile...
3.
Markovetz M, Garbarine I, Morrison C, Kissner W, Seim I, Gregory Forest M, et al.
J Cyst Fibros
. 2022 Apr;
21(6):959-966.
PMID: 35437233
Background: Mucus hyperconcentration in cystic fibrosis (CF) lung disease is marked by increases in both mucin and DNA concentration. Additionally, it has been shown that half of the mucins present...
4.
Kato T, Radicioni G, Papanikolas M, Stoychev G, Markovetz M, Aoki K, et al.
Sci Adv
. 2022 Apr;
8(13):eabm9718.
PMID: 35363522
Cystic fibrosis (CF) is characterized by abnormal transepithelial ion transport. However, a description of CF lung disease pathophysiology unifying superficial epithelial and submucosal gland (SMG) dysfunctions has remained elusive. We...
5.
Morrison C, Edwards C, Shaffer K, Araba K, Wykoff J, Williams D, et al.
Proc Natl Acad Sci U S A
. 2022 Mar;
119(16):e2119680119.
PMID: 35353667
Muco-obstructive lung diseases are typically associated with high risks of COVID-19 severity; however, allergic asthma showed reduced susceptibility. To investigate viral spread, primary human airway epithelial (HAE) cell cultures were...
6.
Morrison C, Shaffer K, Araba K, Markovetz M, Wykoff J, Quinney N, et al.
Eur Respir J
. 2021 Jun;
59(2).
PMID: 34172469
Question: Cystic fibrosis (CF) is characterised by the accumulation of viscous adherent mucus in the lungs. While several hypotheses invoke a direct relationship with cystic fibrosis transmembrane conductance regulator (CFTR)...
7.
Escobar Y, Morrison C, Chen Y, Hickman E, Love C, Rebuli M, et al.
Am J Physiol Lung Cell Mol Physiol
. 2021 Apr;
320(6):L1064-L1073.
PMID: 33825493
In the United States, millions of adults use electronic cigarettes (e-cigs), and a majority of these users are former or current cigarette smokers. It is unclear, whether prior smoking status...
8.
Kato T, Mikami Y, Sun L, Rogers T, Grubb B, Morrison C, et al.
Am J Respir Cell Mol Biol
. 2021 Mar;
64(6):760-764.
PMID: 33788673
No abstract available.
9.
Markovetz M, Subramani D, Kissner W, Morrison C, Garbarine I, Andrew Ghio , et al.
Am J Physiol Lung Cell Mol Physiol
. 2019 Aug;
317(4):L498-L509.
PMID: 31389736
Muco-obstructive lung diseases (MOLDs), like cystic fibrosis and chronic obstructive pulmonary disease, affect a spectrum of subjects globally. In MOLDs, the airway mucus becomes hyperconcentrated, increasing osmotic and viscoelastic moduli...
10.
Esther Jr C, Muhlebach M, Ehre C, Hill D, Wolfgang M, Kesimer M, et al.
Sci Transl Med
. 2019 Apr;
11(486).
PMID: 30944166
Although destructive airway disease is evident in young children with cystic fibrosis (CF), little is known about the nature of the early CF lung environment triggering the disease. To elucidate...